The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...
Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...
NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
ST LOUIS, MO — Stereotactic delivery of external-beam radiation can potentially be used to ablate the source of ventricular tachycardia (VT) that has resisted other drug and device treatments, ...
BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
Please provide your email address to receive an email when new articles are posted on . High-risk patients getting catheter ablation for ventricular tachycardia did not benefit from a mechanical ...
Loyola Medicine is the only center in the Midwest enrolling patients in a landmark clinical trial of a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia.
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today announced ...
Catheter ablation guided by electroanatomic mapping is now a viable treatment option to reduce episodes of recurrent ventricular tachycardia (VT) in patients who have experienced myocardial infarction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback